Has the COVID-19 Pandemic Changed Parental Attitudes and Beliefs Regarding Vaccinating their Children against the Flu?

Study participants and survey design

We conducted a cross-sectional online survey of 975 Israeli parents to children between the ages of 6 months and 11 years during December 21–31, 2022. The survey was distributed by Sarid Research Institute for Research Services via an online panel containing a wide pool of potential interviewees who had consented to participate in surveys from time to time. Eligible participants were required to be (1) 18+ years old and (2) parents of a child aged 6 months to 11 years. To compose a representative sample of the Jewish adult population in Israel, respondents were sampled by layers based on age, gender, geographic area, and level of religiosity. The questionnaire was pre-tested on a relatively small group of 100 respondents. After the reliability of the questionnaire was verified using a Cronbach α internal reliability test (the HBM section of the questionnaire obtained an internal consistency of Cronbach α=0.85), it was distributed to the rest of the respondents.

Questionnaire

The questionnaire (Supplementary Questionnaire 1) consisted of 34 mandatory questions, divided into the following sections: (1) Socio-demographic predictor variables; (2) Health-related predictor variables; (3) HBM predictor variables; and (4) Issues related to public health policy (e.g., getting vaccinated at school).

Variables and measurements

The first dependent variable was parents’ willingness to vaccinate their children aged 6 months to 11 years against the flu in the winter of 2023 (December 2020– February 2023), measured in 3 categories: (1) Yes, I have already vaccinated my child; (2) I intent to vaccinate my child in the current winter, and (3) No, I have not vaccinated my child and do not intend to.

The independent variables were grouped into three blocks:

1. Socio-demographic predictor variables: (1) age group; (2) gender; (3) level of education; (4) marital status; (5) socio-economic level¹; (6) periphery level, determined by the residential area²; (7) religiosity level (secular, traditional, religious, orthodox); and (8) working as medical staff.

2. Health-related predictor variables: (1) whether the respondent got vaccinated against COVID-19; (2) whether the respondent already got vaccinated against flu this winter (i.e., around December 2022); (3) whether the children of the respondent got vaccinated against COVID-19; (4) whether a family member suffers from a chronic disease (one or more of the following: heart disease, vascular disease and/or stroke, diabetes mellitus, hypertension, chronic lung disease, including asthma or immune suppression); (5) the existence of past episodes of flu in the current winter; (6) the existence of past episodes of hospitalization in the family in the current winter.

3. HBM predictor variables: (1) perceived susceptibility (included two items); (2) perceived severity (included two items); (3) perceived benefits (included three items); (4) perceived barriers (included one item); (5) cues to action (included three items); and (6) attitude (included one item). The HBM items were measured on a 1–6 scale (1 - strongly disagree; 6 - strongly agree). Negative items were reverse scored. Scores for each item were averaged to generate each of the HBM-independent categories. The Cronbach α internal reliability method revealed the internal consistency of the HBM section to be Cronbach α=0.86 (Supplementary Table 1).

In addition, several issues related to public health policy were examined: (1) public trust in pharmaceutical companies and the Ministry of Health following the COVID-19 pandemic; (2) the main reasons for the reluctancy to vaccinate children against the flu in the winter of 2023; and (3) the main reasons for preferring to vaccinate children in grades 2–4 against flu at the HMO clinic instead of at school (both options are free of charge in Israel).

Statistical analyses

Data from the online questionnaires were analyzed using SPSS 28 software. To test the reliability of the HBM measures, a Cronbach’s α test was used. To describe the characteristics of the study population, the following methods of descriptive statistics were employed: frequencies, percentages, averages, and standard deviations.

Relationships between dependent and independent variables were examined by univariate analysis. To test the relationship between the demographic variables and willingness to receive a flu vaccine, a series of χ² tests were used. To test the mean differences of the HBM variables at different levels of flu vaccine willingness, we used analysis of variance (ANOVA) tests. Eta squared was used to measure the effect size for significant effects.

To test the multivariate effect of all the significant demographic and health-related variables along with the effects of the HBM variables on willingness to get a flu shot, a multinomial logistic regression analysis was conducted. Only the socio-demographic and health-related variables found to be significant (p<.05) in the univariate analysis were inserted into the regression model as predictors. All the HBM variables were entered into the model as predictors.

Participant characteristics

Overall, 975 parents of children aged 6 months to 11 years completed the survey; 52% of them were female (n=505). Almost two thirds of the parents (n=617) were 18– 39 years old. The participants were distributed nearly equally among the three socio-economic categories (low, medium, and high), with 16% of respondents (n=156) living in geographically peripheral regions. Forty percent of the respondents (n=417) were secular, 59% (n=578) held an academic degree, most (89%, n=869) were married, and 25% (n=239) stated having a family member with a chronic disease. The descriptive characteristics of the respondents are provided in Table 1.

A comparison of the sample and the entire population in terms of the characteristics used for sampling (i.e., age, gender, level of religiosity, and geographical area) is provided in Supplementary Table 2.

Rate of intention to vaccinate children

When parents were asked about their willingness to vaccinate their children aged 6 months to 11 years against the flu in the winter of 2023, 45% (n = 435) stated they had not vaccinated and did not intend to vaccinate their children; 39% (n= 378) responded that they had already vaccinated their children; and the remainder, 16% (n=160), responded that they intend to vaccinate their children. Among those whose children had already been vaccinated or intend to vaccinate, 41% stated that their intention increased following the COVID-19 pandemic.

Univariate analyses: vaccinate children aged 6 months to 11 years against flu

The results of the univariate analyses between the socio-demographic and health-related variables of parents and their willingness to vaccinate their children aged 6 months to 11 years against the flu are reported in Table 1.

The following socio-demographic variables were found to have a statistically significant correlation (p<0.05) with willingness to vaccinate: age, gender, educational level, medical staff, and religiosity level. The health-related variables found to have a statistically significant correlation (p<0.05) with willingness to vaccinate were: children were vaccinated in the previous year against COVID-19, parent was vaccinated against COVID-19 and/or flu in the current winter.

Specifically, the findings show that women were less likely to vaccinate their offspring compared to men (49% vs. 40%, respectively, χ2 (2)=10.29, p=.006), as were parents under the age of 40 compared to older one (47% vs. 41%, respectively, χ2 (2)=12.49, p=.002), non-academics compared to those with an academic degree (55% vs.40% respectively, χ2 (2)=15.46, p=.02), non-medical occupations compared to medical staff (46% vs. 30%, respectively, χ2 (2)=6.41, p=.04), ultra-orthodox Jews (haredi) compared to secular Jews (60% vs. 39%, respectively, χ2 (6)=26.31, p<.001).

Interestingly, parents whose children did not receive a COVID-19 vaccine in the year 2022 expressed significantly higher recalcitrance to vaccinate their children against flu in the winter of 2023 than those whose children did receive a COVID-19 vaccine in the year 2022 (52% vs. 26%, respectively, χ2 (2)=79.3, p<.001).

Parents who did not vaccinate against COVID-19 were more recalcitrance to vaccinate their children aged 6 months to 11 years against the flu compared to those who were vaccinated (57% vs. 38%, respectively, χ2 (4) =58.17, p<.001). Lastly, parents who did not opt to get vaccinated against the flu in the current winter conveyed greater recalcitrance to vaccinate their children aged 6 months to 11 years against the flu compared to those who were vaccinated (74% vs. 4%, respectively, χ2 (4) =539.36, p<.001).

No significant difference was found for the other demographic variables assessed, i.e., socio-economic level, marital status, periphery level, a family member with a chronic disease, past parental episodes of flu in the current winter, and past episodes of hospitalization in the family in the previous year.

The results of the analysis of variance (ANOVA) aimed at testing the mean differences between the HBM variables at the different levels of readiness to vaccinate children aged 6 months to 11 years against flu in the winter of 2023 are reported in Table 2. The perceived susceptibility (F(2,970)=361.7, p<.001, η2=.43), perceived severity (F(2,970)=15.47, p<.001, η2=.03) perceived benefits (F(2,970)=393.47, p<.001, η2=.45) perceived barriers (F(2,970)=94.9, p<.001, η2=.16), cues to action (F(2,970)=281.29, p<.001, η2=.37) and attitude (F(2,970)=53.43, p<.001, η2=.10) all had a statistically significant effect on parents’ willingness to vaccinate their offspring.

Multivariate analyses: predictors of willingness to vaccinate children against flu

We performed a multinomial logistic regression analysis of the multivariate effect of all the significant demographic and health-related variables along with those of the HBM variables on the willingness of parents to vaccinate their children aged 6 months to 11 years against the flu. The regression analysis accounted for an estimated 71% of the explained variance in the willingness to vaccinate children aged 6 months to 11 years against the flu in the winter of 2023 (Nagelkerke Pseudo R²=.71) (see full regression coefficients in Table 3). While none of the socio-demographic variables were significantly associated with the willingness to vaccinate children aged 6 months to 11 years against the flu, four health-related variables were found to be significant predictors. Specifically, an examination of the regression coefficients indicated that when all other variables are controlled, parents who vaccinated their children against COVID-19 in the previous year were 2.52 times more likely to vaccinate their children against the flu in the winter of 2023 than those who did not vaccinate their children against COVID-19 in the previous year (OR=2.52, 95% CI. 1.28–4.95, p=.01). Yet, parents who themselves got vaccinated against COVID-19 were 0.57 times less likely to vaccinate their children for flu in comparison to parents who did not opt for a COVID-19 vaccine (OR=0.57, 95% CI. 0.35– 0.93, p=.03). In the case of parents who got a flu shot in the winter of 2023, they were 24.37 times more likely to vaccinate their children against the flu and 6.25 times more likely to intend to vaccinate their children against the flu in comparison to those who did not get a flu shot that winter (OR=24.37, 95% CI. 8.28–71.74, p<.001; OR=6.25, 95% CI. 1.92–20.29, p<.001). Parents who intended to get a flu shot were 9.3 more likely to vaccinate their children against the flu and 16.46 times more likely to intend to vaccinate their children against the flu in the same winter in comparison to those who did not get a flu shot (OR=9.3, 95% CI. 4.31–20.07, p<.001, OR=16.46, 95% CI. 7.59–35.69, p<.001).

All the HBM tested variables were found to be significant predictors of the willingness of parents to vaccinate their children aged 6 months to 11 years against the flu. Specifically, for each unit increase in susceptibility, the odds of vaccinating increased by 1.88-fold, similar to the odds of intending to vaccinate by 1.89-fold (p<.001). For each unit increase in severity, the odds of vaccinating increased by 1.82-fold (p<.001). For each unit increase in benefits, the odds of vaccinating increased by 2.65-fold, and the odds of intending to vaccinate by 1.86-fold (p<.001). For each unit increase in barriers, the odds of vaccinating decreased by .75-fold, and the odds of intending to vaccinate by .74-fold (p=.01). For each unit increase in cues to action, the odds of vaccinating increased by 1.45-fold and the odds of intending to vaccinate by 1.37-fold (p=.01). A complete description of the model, goodness of fit indices and regression coefficients are presented in Table 3.

Main reasons for the reluctancy to vaccinate children against the flu in the winter of 2023

Forty five percent (n=435) of the parents did not vaccinate and did not intend to vaccinate their children against the flu in the winter of 2023. The most common reasons for this decision were fear of side-effects of the vaccine (28%) and concerns about vaccine effectiveness (22%). Other reasons were a lack of trust in the Ministry of Health (13%) or in pharmaceutical companies and vaccines (13%); of these 169 parents, 132 (78%) stated that the lack of trust increased following the COVID-19 events. Another stated reason was the impression that natural vaccination affords greater protection than an injected vaccine (17%) (see Supplementary Table 3 for the complete list of reasons).

The main reasons for preferring to vaccinate children in grades 2–4 against the flu at a HMO instead of at the school

The main reasons that parents opted to vaccinate their children in grades 2–4 at a HMO clinic rather than through the Student Health Services at the elementary school during school hours with a nasal spray (n=188) were: preference to vaccinate in the presence of the parent (36%), no nurse availability, so there were no vaccination campaign at the school (23%), wanted to vaccinate the children at school, but missed the vaccination day at school (16%), and considering the nasal spray to be not effective, whereas the HMO clinics administered flu shots, perceived by the parent to be more effective (12%).

Discussion

In this study, we examined parents’ willingness to vaccinate their children aged 6 months to 11 years against the flu following the COVID-19 pandemic, in the winter of 2023, and to identify contributing factors to parental decision-making in this regard, including socio-demographic, health-related, and behavioral factors. In addition, we explored parents’ attitudes toward vaccinating their children in school settings as part of Student Health Services.

Previous research has examined parents’ attitudes towards vaccinating their children against the flu, although only a few studies have explored this in the context of the COVID-19 pandemic. The present study found that almost half of the parents who participated in the surveyed did not intend to vaccinate their children against the flu in the winter of 2023. Of the remaining 55%, 39% had already vaccinated their kids, and 16% intended to do so. These findings are consistent with a recent study conducted at the end of 2022 in 14 Eastern Mediterranean region (EMR) countries, which demonstrated that half of parents in these countries were hesitant about vaccinating their children against influenza (Fadl et al., 2023). It is also in line with a study conducted among Chinese middle-school students, which found an overall vaccination rate of 38.2% in this group (Asihaer et al., 2022).

The socio-demographic characteristics we found to be associated with parents’ willingness to vaccinate their children against the flu were, too, in line with previous studies. These factors include male gender (Kini et al., 2022), older parents (Li et al., 2022), higher levels of education (Li et al., 2022), and a medical profession (Sallam et al., 2022). These findings underscore the need to consider socio-demographic factors when designing interventions and campaigns to increase vaccine uptake.

In the hierarchical regression analysis, the HBM variables perceived susceptibility, perceived severity, and perceived benefits displayed the largest effect sizes. This finding highlights these constructs’ importance as predictors of vaccine acceptance and their utility as targets for interventions aimed at promoting health behaviors.

Understanding the impact of the COVID-19 pandemic on parents’ willingness to vaccinate their children against the flu post-pandemic is crucial. As our findings indicate, the pandemic has led to greater vaccine receptivity among some parents. Notably, approximately 41% of parents whose children have already been vaccinated or are planning to get vaccinated reported an increase in their intention to vaccinate against the flu following the pandemic. These findings are consistent with a systematic review that highlighted a rise in the intention to vaccinate against the flu during the pandemic (Kong et al., 2022). Thus, the pandemic has provided a window of opportunity to promote influenza vaccination and decrease vaccine hesitancy among parents. Encouragingly, the increased awareness as to the importance of vaccination due to the COVID-19 pandemic could lead to improved vaccination rates and better protection against both influenza and COVID-19.

While the pandemic has increased awareness to the importance of vaccination, it has also heightened vaccine hesitancy among some parents, particularly those skeptical about vaccines in general. Most of the parental concerns raised in this study center around vaccine safety and efficacy issues. As has been previously reported, vaccine safety and potential side-effects are the main barriers to vaccination (Asihaer et al., 2022; Price et al., 2022). Interestingly, lack of trust in the Ministry of Health and in the pharmaceutical companies increased among 78% of the vaccine skeptics in our study following the COVID-19 events. This lack of trust can arise from a range of factors, such as misinformation, lack of transparency and conspiracy theories about vaccines, all of which contribute to confusion and mistrust among some parents. It is, therefore, important that healthcare providers and public health officials address these concerns and provide accurate information about the safety and efficacy of the influenza vaccine and work towards rebuilding trust in the Ministry of Health to help increase the vaccination rate among parents and children.

Our results further indicate that only 37% of parents to kids in grades 2–4 chose to vaccinate their children at school, mainly because they preferred doing so at the HMO clinic in their presence or due to the unavailability of a nurse to administer the vaccine at the school. The lack of personnel at the school may lead parents to opt for alternative vaccination options, such as visiting the HMO clinic. Overall, while implementing school-based vaccination programs may be challenging, it is an important strategy for improving vaccination rates and promoting public health. Indeed, a recent study found that sending a behaviorally informed invitation letter and reminders can increase childhood influenza vaccinations through schools and general practitioner (GP) practices (Howell-Jones et al., 2023).

Nevertheless, it is important to recognize this study’s limitations when interpreting the reported results. First, it is important to be aware of the predictive limitation of a cross-sectional study. Namely, since the exposure and outcome are simultaneously assessed, it is not possible to determine a temporal or causal relationship between them, Therefore, it cannot be ruled out that other variables created pseudo-correlations. Moreover, the study used self-report of influenza vaccine acceptance and intention to influenza vaccine in the coming winter, but the self-report of actual behavior may be biased, unlike monitoring actual vaccination. Finally, the study used a cross-sectional observational design that does not allow one to derive any causal conclusions.

Conclusions

Understanding the impact of the COVID-19 pandemic on parents’ willingness to vaccinate their children against the flu is crucial. Notably, the pandemic has led to enhanced vaccine receptivity among some parents. Healthcare providers and public health officials should address parents’ concerns about the safety and efficacy of the influenza vaccine as a means to improve vaccination rates among children. Implementing school-based vaccination programs is an important strategy for promoting public health, but may be challenging. To increase uptake, nursing staff in student health facilities should be more accessible, and clear explanations about the efficacy of nasal spray vaccinations should be provided.